Page last updated: 2024-10-24

cetyltrimethylammonium ion and Xerophthalmia

cetyltrimethylammonium ion has been researched along with Xerophthalmia in 1 studies

Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.

Xerophthalmia: Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.

Research Excerpts

ExcerptRelevanceReference
" Adverse events were reported for 21 patients in the Lacrinorm group and 17 in the reference group, the most frequent being discomfort, blurred vision, hyperaemia, burning and itching."2.69Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears. ( Bron, AJ; Daubas, P; Siou-Mermet, R; Trinquand, C, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bron, AJ1
Daubas, P1
Siou-Mermet, R1
Trinquand, C1

Trials

1 trial available for cetyltrimethylammonium ion and Xerophthalmia

ArticleYear
Comparison of the efficacy and safety of two eye gels in the treatment of dry eyes: Lacrinorm and Viscotears.
    Eye (London, England), 1998, Volume: 12 ( Pt 5)

    Topics: Acrylic Resins; Adult; Aged; Benzalkonium Compounds; Cetrimonium; Cetrimonium Compounds; Double-Blin

1998